2709
Women (aged < or = 75 yr; > or = 2 yr since their last menstrual period) received placebo, RLX 60 mg/d, ALN 10 mg/d, or RLX 60 mg/d and ALN 10 mg/d combined.
 ( potential therapeutic event: received ,  Women (aged < or = 75 yr; > or = 2 yr since their last menstrual period): Subject, Women: Subject.Gender, aged < or = 75 yr; > or = 2 yr: Subject.Age, RLX 60 mg/d, ALN 10 mg/d, or RLX 60 mg/d and ALN 10 mg/d combined: Treatment, 60 mg/d: Treatment.Dosage, 10 mg/d: Treatment.Dosage, 60 mg/d: Treatment.Dosage, 10 mg/d: Treatment.Dosage, RLX: Treatment.Drug, ALN: Treatment.Drug, RLX: Treatment.Drug, ALN: Treatment.Drug, ALN: Combination.Drug, RLX: Combination.Drug) 
Locate the role in the text that participated in the event based on the event type and return it in the event list. 
 Option: Event type: adverse event,potential therapeutic event, Arguments type: Treatment.Disorder,Treatment.Time_elapsed,Treatment.Dosage,Subject.Race,Treatment.Drug,Treatment.Route,Subject.Disorder,Treatment.Freq,Treatment,Effect,Subject.Population,Treatment.Duration,Combination.Drug,Subject,Subject.Age,Subject.Gender. 
Text: {0} 
Answer:
 ( potential therapeutic event: received ,  Women (aged < or = 75 yr; > or = 2 yr since their last menstrual period): Subject, Women: Subject.Gender, aged < or = 75 yr; > or = 2 yr: Subject.Age, RLX 60 mg/d, ALN 10 mg/d, or RLX 60 mg/d and ALN 10 mg/d combined: Treatment, 60 mg/d: Treatment.Dosage, 10 mg/d: Treatment.Dosage, 60 mg/d: Treatment.Dosage, 10 mg/d: Treatment.Dosage, RLX: Treatment.Drug, ALN: Treatment.Drug, RLX: Treatment.Drug, ALN: Treatment.Drug, ALN: Combination.Drug, RLX: Combination.Drug) 